These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

336 related articles for article (PubMed ID: 25605429)

  • 1. miR-21 regulates triglyceride and cholesterol metabolism in non-alcoholic fatty liver disease by targeting HMGCR.
    Sun C; Huang F; Liu X; Xiao X; Yang M; Hu G; Liu H; Liao L
    Int J Mol Med; 2015 Mar; 35(3):847-53. PubMed ID: 25605429
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dicer1/miR-29/HMGCR axis contributes to hepatic free cholesterol accumulation in mouse non-alcoholic steatohepatitis.
    Liu MX; Gao M; Li CZ; Yu CZ; Yan H; Peng C; Li Y; Li CG; Ma ZL; Zhao Y; Pu MF; Miao LL; Qi XM; Ren J
    Acta Pharmacol Sin; 2017 May; 38(5):660-671. PubMed ID: 28112179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-26a Potentially Contributes to the Regulation of Fatty Acid and Sterol Metabolism In Vitro Human HepG2 Cell Model of Nonalcoholic Fatty Liver Disease.
    Ali O; Darwish HA; Eldeib KM; Abdel Azim SA
    Oxid Med Cell Longev; 2018; 2018():8515343. PubMed ID: 30402207
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA 27a Is a Key Modulator of Cholesterol Biosynthesis.
    Khan AA; Agarwal H; Reddy SS; Arige V; Natarajan B; Gupta V; Kalyani A; Barthwal MK; Mahapatra NR
    Mol Cell Biol; 2020 Apr; 40(9):. PubMed ID: 32071155
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-190b regulates lipid metabolism and insulin sensitivity by targeting IGF-1 and ADAMTS9 in non-alcoholic fatty liver disease.
    Xu M; Zheng XM; Jiang F; Qiu WQ
    J Cell Biochem; 2018 Jul; 119(7):5864-5874. PubMed ID: 29575055
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-185 regulates expression of lipid metabolism genes and improves insulin sensitivity in mice with non-alcoholic fatty liver disease.
    Wang XC; Zhan XR; Li XY; Yu JJ; Liu XM
    World J Gastroenterol; 2014 Dec; 20(47):17914-23. PubMed ID: 25548489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway.
    Hur W; Lee JH; Kim SW; Kim JH; Bae SH; Kim M; Hwang D; Kim YS; Park T; Um SJ; Song BJ; Yoon SK
    Int J Biochem Cell Biol; 2015 Jul; 64():265-76. PubMed ID: 25957914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21.
    Xiao J; Bei Y; Liu J; Dimitrova-Shumkovska J; Kuang D; Zhou Q; Li J; Yang Y; Xiang Y; Wang F; Yang C; Yang W
    J Cell Mol Med; 2016 Feb; 20(2):204-16. PubMed ID: 26648452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered microRNA-9 Expression Level is Directly Correlated with Pathogenesis of Nonalcoholic Fatty Liver Disease by Targeting Onecut2 and SIRT1.
    Ao R; Wang Y; Tong J; Wang BF
    Med Sci Monit; 2016 Oct; 22():3804-3819. PubMed ID: 27756894
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-98 regulates hepatic cholesterol metabolism via targeting sterol regulatory element-binding protein 2.
    Geng C; Dong T; Jin W; Yu B; Yin F; Peng F; Chen G; Ji C; Ding F
    Biochem Biophys Res Commun; 2018 Oct; 504(2):422-426. PubMed ID: 30195495
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease.
    Min HK; Kapoor A; Fuchs M; Mirshahi F; Zhou H; Maher J; Kellum J; Warnick R; Contos MJ; Sanyal AJ
    Cell Metab; 2012 May; 15(5):665-74. PubMed ID: 22560219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-185-5p mediates regulation of SREBP2 expression by hepatitis C virus core protein.
    Li M; Wang Q; Liu SA; Zhang JQ; Ju W; Quan M; Feng SH; Dong JL; Gao P; Cheng J
    World J Gastroenterol; 2015 Apr; 21(15):4517-25. PubMed ID: 25914460
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA-205 ameliorates lipid accumulation in non-alcoholic fatty liver disease through targeting NEU1.
    Hu Y; Ye H; Shi LX
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):10072-10082. PubMed ID: 31799678
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.
    Wang L; Sun M; Cao Y; Ma L; Shen Y; Velikanova AA; Li X; Sun C; Zhao Y
    Arch Biochem Biophys; 2020 Nov; 695():108642. PubMed ID: 33098868
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of miR-125b by estrogen protects against non-alcoholic fatty liver in female mice.
    Zhang ZC; Liu Y; Xiao LL; Li SF; Jiang JH; Zhao Y; Qian SW; Tang QQ; Li X
    J Hepatol; 2015 Dec; 63(6):1466-75. PubMed ID: 26272872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Down-Regulation of SIRT1 Expression by mir-23b Contributes to Lipid Accumulation in HepG2 Cells.
    Borji M; Nourbakhsh M; Shafiee SM; Owji AA; Abdolvahabi Z; Hesari Z; Ilbeigi D; Seiri P; Yousefi Z
    Biochem Genet; 2019 Aug; 57(4):507-521. PubMed ID: 30697640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the SIRT1/p66shc antiapoptosis pathway via carnosic acid-induced inhibition of miR-34a protects rats against nonalcoholic fatty liver disease.
    Shan W; Gao L; Zeng W; Hu Y; Wang G; Li M; Zhou J; Ma X; Tian X; Yao J
    Cell Death Dis; 2015 Jul; 6(7):e1833. PubMed ID: 26203862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-222 targets ACOX1, promotes triglyceride accumulation in hepatocytes.
    Wang JJ; Zhang YT; Tseng YJ; Zhang J
    Hepatobiliary Pancreat Dis Int; 2019 Aug; 18(4):360-365. PubMed ID: 31126802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of miR-181a impairs lipid metabolism by targeting PPARĪ± expression in nonalcoholic fatty liver disease.
    Huang R; Duan X; Liu X; Cao H; Wang Y; Fan J; Wang B
    Biochem Biophys Res Commun; 2019 Jan; 508(4):1252-1258. PubMed ID: 30558790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fermented Rhus verniciflua Stokes Extract Exerts an Antihepatic Lipogenic Effect in Oleic-Acid-Induced HepG2 Cells via Upregulation of AMP-Activated Protein Kinase.
    Lee MS; Kim JS; Cho SM; Lee SO; Kim SH; Lee HJ
    J Agric Food Chem; 2015 Aug; 63(32):7270-6. PubMed ID: 26176317
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.